Are benztropine and Vistaril (hydroxyzine) both anticholinergic agents?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, benztropine and Vistaril (hydroxyzine) are not both anticholinergic agents in the same way—benztropine is a potent anticholinergic medication, while Vistaril has minimal anticholinergic activity and is primarily an antihistamine.

Key Pharmacological Differences

Benztropine possesses strong anticholinergic properties that are therapeutically significant for managing parkinsonism, with anticholinergic activity approximately equal to atropine in isolated tissue studies 1. This medication directly inhibits muscarinic cholinergic receptors and causes substantial anticholinergic burden, including memory impairment, dry mouth, blurred vision, and decreased salivary flow 2.

Vistaril (hydroxyzine), in contrast, is primarily an antihistamine with bronchodilator, antihistaminic, and analgesic effects 3. While it does have some anticholinergic properties, these are significantly weaker than benztropine. Research demonstrates that hydroxyzine-poisoned patients develop antimuscarinic findings far less frequently than diphenhydramine-poisoned patients, and are more likely to present with mild CNS depression rather than an anticholinergic toxidrome 4. In comparative studies, hydroxyzine ranked low in anticholinergic potency compared to other antihistamines 5.

Clinical Implications

Anticholinergic Burden Considerations

  • Benztropine carries substantial anticholinergic risk, particularly in elderly patients, causing cognitive decline, impaired memory storage, falls, delirium, and functional decline 6, 2
  • Hydroxyzine has lower anticholinergic burden but still warrants caution in elderly populations due to sedation and some anticholinergic effects 7, 8
  • Both medications appear on lists of potentially inappropriate medications for older adults, but for different primary reasons—benztropine for strong anticholinergic effects, hydroxyzine primarily for sedation 6

Prescribing Guidance

For benztropine: Limit prophylactic use to ≤7 days when preventing antipsychotic-induced dystonia 9. The strong anticholinergic effects impair free recall, time perception, and cause significant dry mouth and blurred vision 2.

For hydroxyzine: First-generation antihistamines like hydroxyzine cause sedation, drowsiness, and performance impairment—but these effects are primarily histaminergic and serotonergic, not predominantly anticholinergic 8, 10, 8. The medication does have some anticholinergic properties including dry mouth 3, but these are mild compared to benztropine.

Common Pitfall to Avoid

Do not assume all sedating medications have equivalent anticholinergic properties. Many clinicians incorrectly attribute sedation from hydroxyzine to anticholinergic effects, when sedation is actually due to potent antihistaminic (H1 receptor) activity 11. This distinction matters because anticholinergic medications specifically impair cognition and memory through muscarinic receptor blockade, while antihistaminic sedation operates through different mechanisms.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.